An official website of the United States government Here’s how you know

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

In this section: Cellular & Gene Therapy Products

CARVYKTI

STN:125746
Proper Name: ciltacabtagene autoleucel
Tradename: CARVYKTI
Manufacturer: Janssen Biotech, Inc.
Indications:

Treatment of adult patients with relapsed or refractory multiple myeloma who have received at least one prior line of therapy, including a proteasome inhibitor and an immunomodulatory agent, and are refractory to lenalidomide.

Product Information

Package Insert and Medication Guide - CARVYKTI

Supporting Documents

Top